OR WAIT null SECS
July 02, 2011
Member states in the EU are working to implement the newly passed Falsified Medicines Directive.
May 02, 2011
Eastern Europe's pharmaceutical leader, Hungary, is working to maintain its number-one status while also pursuing new avenues, especially in biopharmaceuticals.
January 02, 2011
The European Commission and Medicines Agency seem to be moving in advance of their ICH partners to update standards.
October 02, 2010
Public-private R&D partnerships are on the rise across Europe, but national goals and academia-industry competition could prevent their success at the European level.
June 02, 2010
Europe moves to place excipient GMP and GDP standards on the same level as active pharmaceutical ingredients.
February 02, 2010
Regulators and industry move to require inspections of API manufacturing facilities.
June 02, 2009
Despite its shrinking domestic economy, Ireland is determined not to let its pharmaceutical industry fade into the shadow of global recession.
April 30, 2009
As the pharma industry desperately seeks to cut costs and streamline production, a new breed of CMO is growing in Europe. Find out how today's CMO is capitalizing on pharma's plant closures and divestments.
April 02, 2009
Although industry is tightening its belt, contract manufacturers across Europe are actually making out quite well by taking on additional projects and new roles.
October 02, 2008
Although the European Union's approval rates of biosimilars for market is increasing slower than expected, its approach may provide an example for other foreign markets.